sodium iodide I-131
Selected indexed studies
- Sodium Iodide I 131. (, 2006) [PMID:30000623]
- Sodium Iodide I 131. (, 2026) [PMID:32310605]
- ACR-ACNM-ARS-SNMMI-SPR Practice Parameter for Treatment of Benign and Malignant Thyroid Disease With I-131 Sodium Iodide. (Am J Clin Oncol, 2026) [PMID:40694360]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Sodium Iodide I 131. (2006) pubmed
- Sodium Iodide I 131. (2026) pubmed
- ACR-ACNM-ARS-SNMMI-SPR Practice Parameter for Treatment of Benign and Malignant Thyroid Disease With I-131 Sodium Iodide. (2026) pubmed
- Anti-EpCAM Functionalized I-131 Radiolabeled Biomimetic Nanocarrier Sodium/Iodide-Symporter-Mediated Breast-Cancer Treatment. (2022) pubmed
- I-123 Uptake. (2026) pubmed
- I-131 false-positive uptake in a thymic cyst with expression of the sodium-iodide symporter: A case report. (2022) pubmed
- Increasing Analytical Quality by Designing a Thin-Layer Chromatography Scanner Method for the Determination of the Radiochemical Purity of Radiopharmaceutical Sodium Iodide (131)I Oral Solution. (2024) pubmed
- Radiation-Induced Amplification of TGFB1-Induced Mesenchymal Stem Cell-Mediated Sodium Iodide Symporter (NIS) Gene (131)I Therapy. (2019) pubmed
- Sodium iodide I 131 treatment of dogs with nonresectable thyroid tumors: 39 cases (1990-2003). (2006) pubmed
- Real-world Data on Intermediate-risk Differentiated Thyroid Cancer Biochemical Response to 3700 or 5550 MBq of [(131)I]Sodium Iodide. (2025) pubmed